The incidence of end-stage renal disease (ESRD) in the United States is increasing dramatically and renal transplantation is the best treatment for many of these patients. The results of kidney transplantation also have improved. This has resulted in a significant demand for organs that is not met by the current supply of deceased donors. There now are more living kidney donors than cadaveric donors because the results of living donor renal transplantation are superior and the prolonged wait for a cadaveric kidney transplant can be avoided. Therefore, urologists will have increasing exposure to patients with ESRD and those with renal transplantation.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.United States Renal Data System 2003 Annual Data Report. http://www.usrds.org/adr.htm. Accessed September 22, 2004. This Internet site is updated annually and includes tables that are easily understood and graphs that clearly show the impact of ESRD.Google Scholar
- 6.Organ Procurement and Transplantation/Scientific Registry of Transplant Recipients 2003 Annual Report. http://www.ustransplant.org. Accessed September 22, 2004. This Internet site is updated continuously with organ donation and transplant statistics. The annual report provides national and center specific statistics.Google Scholar
- 12.Cecka JM: The UNOS Renal Transplant Registry. Clin Transpl 2002, 1–20.Google Scholar
- 17.Danovitch GM, Hariharan S, Pirsch J, et al.: Management of the waiting list of cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2001, 13:528–535.Google Scholar
- 20.Danovitch GM: Handbook of Kidney Transplantation. Philadelphia: Lippincott Williams & Wilkins; 2004. This concise handbook provides current information on all aspects of renal transplantation. The chapter organization quickly answers questions regarding the evaluation and management of renal transplant recipients.Google Scholar
- 27.Danovitch GM: How should the immunosuppressive regimen be managed in patients with established chronic allograft failure? Kidney Int Suppl 2002, 68–72.Google Scholar
- 29.Tebyani N, Gritsch HA: Renal cell carcinoma in dialysis and transplantation. In Renal and Adrenal Tumors. Edited by Belldegrun A, Ritchie AW, Figlin RA, et al. New York; Oxford University Press; 2003:74.Google Scholar
- 30.Pirsch JD, Sollinger HW, Smith CV: Kidney and pancreas transplantation in diabetic patients. In Handbook of Kidney Transplantation. Edited by Danovitch GM. Philadelphia: Lippincott Williams & Wilkins; 2004:390.Google Scholar